カテゴリー： LP Information, 世界, 医療/バイオ

世界の口唇ヘルペス薬市場予測 2021年-2026年

【英語タイトル】Global Herpes Labialis Drugs Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9635）・商品コード：LPI21MY9635
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：167
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「口唇ヘルペス薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他など、用途別には、外用、経口、注射などにセグメント区分してまとめました。口唇ヘルペス薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・口唇ヘルペス薬の世界市場概要（サマリー）
・口唇ヘルペス薬の企業別販売量・売上
・口唇ヘルペス薬の企業別市場シェア
・口唇ヘルペス薬の世界市場規模 2016年-2021年：種類別（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他）
・口唇ヘルペス薬の世界市場規模 2016年-2021年：用途別（外用、経口、注射）
・口唇ヘルペス薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・口唇ヘルペス薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・口唇ヘルペス薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・口唇ヘルペス薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・口唇ヘルペス薬市場の成長要因・課題・動向
・口唇ヘルペス薬の世界市場予測 2021年-2026年
・口唇ヘルペス薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・口唇ヘルペス薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・口唇ヘルペス薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・口唇ヘルペス薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・口唇ヘルペス薬の世界市場予測：種類別（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他）
・口唇ヘルペス薬の世界市場予測：用途別（外用、経口、注射）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Herpes Labialis Drugs will have significant change from previous year. By the most conservative estimates of global Herpes Labialis Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Herpes Labialis Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Labialis Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
External Use
Oral
Injection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Herpes Labialis Drugs Consumption 2016-2026
2.1.2 Herpes Labialis Drugs Consumption CAGR by Region
2.2 Herpes Labialis Drugs Segment by Type
2.2.1 Valacyclovir
2.2.2 Aciclovir
2.2.3 Famciclovir
2.2.4 Docosanol
2.2.5 Other
2.3 Herpes Labialis Drugs Sales by Type
2.3.1 Global Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Herpes Labialis Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Herpes Labialis Drugs Sale Price by Type (2016-2021)
2.4 Herpes Labialis Drugs Segment by Application
2.4.1 External Use
2.4.2 Oral
2.4.3 Injection
2.5 Herpes Labialis Drugs Sales by Application
2.5.1 Global Herpes Labialis Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Herpes Labialis Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Herpes Labialis Drugs Sale Price by Application (2016-2021)

3 Global Herpes Labialis Drugs by Company
3.1 Global Herpes Labialis Drugs Sales Market Share by Company
3.1.1 Global Herpes Labialis Drugs Sales by Company (2019-2021)
3.1.2 Global Herpes Labialis Drugs Sales Market Share by Company (2019-2021)
3.2 Global Herpes Labialis Drugs Revenue Market Share by Company
3.2.1 Global Herpes Labialis Drugs Revenue by Company (2019-2021)
3.2.2 Global Herpes Labialis Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Herpes Labialis Drugs Sale Price by Company
3.4 Global Manufacturers Herpes Labialis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Herpes Labialis Drugs Product Location Distribution
3.4.2 Players Herpes Labialis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Herpes Labialis Drugs by Region
4.1 Global Herpes Labialis Drugs by Region
4.1.1 Global Herpes Labialis Drugs Sales by Region
4.1.2 Global Herpes Labialis Drugs Revenue by Region
4.2 Americas Herpes Labialis Drugs Sales Growth
4.3 APAC Herpes Labialis Drugs Sales Growth
4.4 Europe Herpes Labialis Drugs Sales Growth
4.5 Middle East & Africa Herpes Labialis Drugs Sales Growth

5 Americas
5.1 Americas Herpes Labialis Drugs Sales by Country
5.1.1 Americas Herpes Labialis Drugs Sales by Country (2016-2021)
5.1.2 Americas Herpes Labialis Drugs Revenue by Country (2016-2021)
5.2 Americas Herpes Labialis Drugs Sales by Type
5.3 Americas Herpes Labialis Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Herpes Labialis Drugs Sales by Region
6.1.1 APAC Herpes Labialis Drugs Sales by Region (2016-2021)
6.1.2 APAC Herpes Labialis Drugs Revenue by Region (2016-2021)
6.2 APAC Herpes Labialis Drugs Sales by Type
6.3 APAC Herpes Labialis Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Herpes Labialis Drugs by Country
7.1.1 Europe Herpes Labialis Drugs Sales by Country (2016-2021)
7.1.2 Europe Herpes Labialis Drugs Revenue by Country (2016-2021)
7.2 Europe Herpes Labialis Drugs Sales by Type
7.3 Europe Herpes Labialis Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Herpes Labialis Drugs by Country
8.1.1 Middle East & Africa Herpes Labialis Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Herpes Labialis Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Herpes Labialis Drugs Sales by Type
8.3 Middle East & Africa Herpes Labialis Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Herpes Labialis Drugs Distributors
10.3 Herpes Labialis Drugs Customer

11 Global Herpes Labialis Drugs Market Forecast
11.1 Global Herpes Labialis Drugs Forecast by Region
11.1.1 Global Herpes Labialis Drugs Forecast by Regions (2021-2026)
11.2.2 Global Herpes Labialis Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Herpes Labialis Drugs Forecast by Type
11.7 Global Herpes Labialis Drugs Forecast by Application

12 Key Players Analysis
12.1 GSK
12.1.1 GSK GSK Company Information
12.1.2 GSK Herpes Labialis Drugs Product Offered
12.1.3 GSK Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GSK Main Business Overview
12.1.5 GSK Latest Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis Herpes Labialis Drugs Product Offered
12.2.3 Novartis Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Herpes Labialis Drugs Product Offered
12.3.3 Teva Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Teva Main Business Overview
12.3.5 Teva Latest Developments
12.4 Mylan
12.4.1 Mylan Company Information
12.4.2 Mylan Herpes Labialis Drugs Product Offered
12.4.3 Mylan Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mylan Main Business Overview
12.4.5 Mylan Latest Developments
12.5 Cadila
12.5.1 Cadila Company Information
12.5.2 Cadila Herpes Labialis Drugs Product Offered
12.5.3 Cadila Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Cadila Main Business Overview
12.5.5 Cadila Latest Developments
12.6 Apotex
12.6.1 Apotex Company Information
12.6.2 Apotex Herpes Labialis Drugs Product Offered
12.6.3 Apotex Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Apotex Main Business Overview
12.6.5 Apotex Latest Developments
12.7 Daewoong Pharmaceutical
12.7.1 Daewoong Pharmaceutical Company Information
12.7.2 Daewoong Pharmaceutical Herpes Labialis Drugs Product Offered
12.7.3 Daewoong Pharmaceutical Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Daewoong Pharmaceutical Main Business Overview
12.7.5 Daewoong Pharmaceutical Latest Developments
12.8 Livzon
12.8.1 Livzon Company Information
12.8.2 Livzon Herpes Labialis Drugs Product Offered
12.8.3 Livzon Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Livzon Main Business Overview
12.8.5 Livzon Latest Developments
12.9 Luoxin
12.9.1 Luoxin Company Information
12.9.2 Luoxin Herpes Labialis Drugs Product Offered
12.9.3 Luoxin Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Luoxin Main Business Overview
12.9.5 Luoxin Latest Developments
12.10 Med shine
12.10.1 Med shine Company Information
12.10.2 Med shine Herpes Labialis Drugs Product Offered
12.10.3 Med shine Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Med shine Main Business Overview
12.10.5 Med shine Latest Developments
12.11 Bayer (Campho Phenique)
12.11.1 Bayer (Campho Phenique) Company Information
12.11.2 Bayer (Campho Phenique) Herpes Labialis Drugs Product Offered
12.11.3 Bayer (Campho Phenique) Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Bayer (Campho Phenique) Main Business Overview
12.11.5 Bayer (Campho Phenique) Latest Developments
12.12 Blistex
12.12.1 Blistex Company Information
12.12.2 Blistex Herpes Labialis Drugs Product Offered
12.12.3 Blistex Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Blistex Main Business Overview
12.12.5 Blistex Latest Developments
12.13 Kelun Group
12.13.1 Kelun Group Company Information
12.13.2 Kelun Group Herpes Labialis Drugs Product Offered
12.13.3 Kelun Group Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Kelun Group Main Business Overview
12.13.5 Kelun Group Latest Developments
12.14 Hikma
12.14.1 Hikma Company Information
12.14.2 Hikma Herpes Labialis Drugs Product Offered
12.14.3 Hikma Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Hikma Main Business Overview
12.14.5 Hikma Latest Developments
12.15 Haiwang
12.15.1 Haiwang Company Information
12.15.2 Haiwang Herpes Labialis Drugs Product Offered
12.15.3 Haiwang Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Haiwang Main Business Overview
12.15.5 Haiwang Latest Developments
12.16 Carmex
12.16.1 Carmex Company Information
12.16.2 Carmex Herpes Labialis Drugs Product Offered
12.16.3 Carmex Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Carmex Main Business Overview
12.16.5 Carmex Latest Developments
12.17 Cipher
12.17.1 Cipher Company Information
12.17.2 Cipher Herpes Labialis Drugs Product Offered
12.17.3 Cipher Herpes Labialis Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Cipher Main Business Overview
12.17.5 Cipher Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Herpes Labialis Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Valacyclovir
Table 3. Major Players of Aciclovir
Table 4. Major Players of Famciclovir
Table 5. Major Players of Docosanol
Table 6. Major Players of Other
Table 7. Global Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 8. Global Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 9. Global Herpes Labialis Drugs Revenue by Type (2016-2021) & ($ million)
Table 10. Global Herpes Labialis Drugs Revenue Market Share by Type (2016-2021)
Table 11. Global Herpes Labialis Drugs Sale Price by Type (2016-2021)
Table 12. Global Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 13. Global Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 14. Global Herpes Labialis Drugs Value by Application (2016-2021)
Table 15. Global Herpes Labialis Drugs Revenue Market Share by Application (2016-2021)
Table 16. Global Herpes Labialis Drugs Sale Price by Application (2016-2021)
Table 17. Global Herpes Labialis Drugs Sales by Company (2019-2021) & (K Pcs)
Table 18. Global Herpes Labialis Drugs Sales Market Share by Company (2019-2021)
Table 19. Global Herpes Labialis Drugs Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Herpes Labialis Drugs Revenue Market Share by Company (2019-2021)
Table 21. Global Herpes Labialis Drugs Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Herpes Labialis Drugs Producing Area Distribution and Sales Area
Table 23. Players Herpes Labialis Drugs Products Offered
Table 24. Herpes Labialis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Herpes Labialis Drugs Sales by Region (2016-2021) (K Pcs)
Table 28. Global Herpes Labialis Drugs Sales Market Share by Region (2016-2021)
Table 29. Global Herpes Labialis Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Herpes Labialis Drugs Revenue Market Share by Region (2016-2021)
Table 31. Americas Herpes Labialis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 32. Americas Herpes Labialis Drugs Sales Market Share by Country (2016-2021)
Table 33. Americas Herpes Labialis Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Herpes Labialis Drugs Revenue Market Share by Country (2016-2021)
Table 35. Americas Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 36. Americas Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 37. Americas Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 38. Americas Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 39. APAC Herpes Labialis Drugs Sales by Region (2016-2021) & (K Pcs)
Table 40. APAC Herpes Labialis Drugs Sales Market Share by Region (2016-2021)
Table 41. APAC Herpes Labialis Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Herpes Labialis Drugs Revenue Market Share by Region (2016-2021)
Table 43. APAC Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 44. APAC Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 45. APAC Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 46. APAC Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 47. Europe Herpes Labialis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 48. Europe Herpes Labialis Drugs Sales Market Share by Country (2016-2021)
Table 49. Europe Herpes Labialis Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Herpes Labialis Drugs Revenue Market Share by Country (2016-2021)
Table 51. Europe Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 52. Europe Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 53. Europe Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 54. Europe Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Herpes Labialis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 56. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Herpes Labialis Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Herpes Labialis Drugs Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Herpes Labialis Drugs Sales by Type (2016-2021) & (K Pcs)
Table 60. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Herpes Labialis Drugs Sales by Application (2016-2021) & (K Pcs)
Table 62. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Table 63. Global Herpes Labialis Drugs Sales Forecast by Type (2021-2026) & (K Pcs)
Table 64. Global Herpes Labialis Drugs Sales Market Share Forecast by Type (2021-2026)
Table 65. Global Herpes Labialis Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 66. Global Herpes Labialis Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 67. Global Herpes Labialis Drugs Sales Forecast by Application (2021-2026) & (K Pcs)
Table 68. Global Herpes Labialis Drugs Sales Market Share Forecast by Application (2021-2026)
Table 69. Global Herpes Labialis Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 70. Global Herpes Labialis Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 71. GSK Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 72. GSK Herpes Labialis Drugs Product Offered
Table 73. GSK Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 74. GSK Main Business
Table 75. GSK Latest Developments
Table 76. Novartis Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 77. Novartis Herpes Labialis Drugs Product Offered
Table 78. Novartis Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. Teva Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Teva Herpes Labialis Drugs Product Offered
Table 83. Teva Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 84. Teva Main Business
Table 85. Teva Latest Developments
Table 86. Mylan Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Mylan Herpes Labialis Drugs Product Offered
Table 88. Mylan Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 89. Mylan Main Business
Table 90. Mylan Latest Developments
Table 91. Cadila Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Cadila Herpes Labialis Drugs Product Offered
Table 93. Cadila Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 94. Cadila Main Business
Table 95. Cadila Latest Developments
Table 96. Apotex Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Apotex Herpes Labialis Drugs Product Offered
Table 98. Apotex Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 99. Apotex Main Business
Table 100. Apotex Latest Developments
Table 101. Daewoong Pharmaceutical Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Daewoong Pharmaceutical Herpes Labialis Drugs Product Offered
Table 103. Daewoong Pharmaceutical Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 104. Daewoong Pharmaceutical Main Business
Table 105. Daewoong Pharmaceutical Latest Developments
Table 106. Livzon Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Livzon Herpes Labialis Drugs Product Offered
Table 108. Livzon Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 109. Livzon Main Business
Table 110. Livzon Latest Developments
Table 111. Luoxin Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Luoxin Herpes Labialis Drugs Product Offered
Table 113. Luoxin Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 114. Luoxin Main Business
Table 115. Luoxin Latest Developments
Table 116. Med shine Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Med shine Herpes Labialis Drugs Product Offered
Table 118. Med shine Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 119. Med shine Main Business
Table 120. Med shine Latest Developments
Table 121. Bayer (Campho Phenique) Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Bayer (Campho Phenique) Herpes Labialis Drugs Product Offered
Table 123. Bayer (Campho Phenique) Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 124. Bayer (Campho Phenique) Main Business
Table 125. Bayer (Campho Phenique) Latest Developments
Table 126. Blistex Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Blistex Herpes Labialis Drugs Product Offered
Table 128. Blistex Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 129. Blistex Main Business
Table 130. Blistex Latest Developments
Table 131. Kelun Group Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Kelun Group Herpes Labialis Drugs Product Offered
Table 133. Kelun Group Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 134. Kelun Group Main Business
Table 135. Kelun Group Latest Developments
Table 136. Hikma Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Hikma Herpes Labialis Drugs Product Offered
Table 138. Hikma Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 139. Hikma Main Business
Table 140. Hikma Latest Developments
Table 141. Haiwang Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Haiwang Herpes Labialis Drugs Product Offered
Table 143. Haiwang Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 144. Haiwang Main Business
Table 145. Haiwang Latest Developments
Table 146. Carmex Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Carmex Herpes Labialis Drugs Product Offered
Table 148. Carmex Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 149. Carmex Main Business
Table 150. Carmex Latest Developments
Table 151. Cipher Basic Information, Herpes Labialis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 152. Cipher Herpes Labialis Drugs Product Offered
Table 153. Cipher Herpes Labialis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 154. Cipher Main Business
Table 155. Cipher Latest Developments
List of Figures
Figure 1. Picture of Herpes Labialis Drugs
Figure 2. Herpes Labialis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herpes Labialis Drugs Sales Growth Rate 2016-2026 (K Pcs)
Figure 7. Global Herpes Labialis Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Herpes Labialis Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Valacyclovir
Figure 10. Product Picture of Aciclovir
Figure 11. Product Picture of Famciclovir
Figure 12. Product Picture of Docosanol
Figure 13. Product Picture of Other
Figure 14. Global Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 15. Global Herpes Labialis Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Herpes Labialis Drugs Consumed in External Use
Figure 17. Global Herpes Labialis Drugs Market: External Use (2016-2021) & (K Pcs)
Figure 18. Herpes Labialis Drugs Consumed in Oral
Figure 19. Global Herpes Labialis Drugs Market: Oral (2016-2021) & (K Pcs)
Figure 20. Herpes Labialis Drugs Consumed in Injection
Figure 21. Global Herpes Labialis Drugs Market: Injection (2016-2021) & (K Pcs)
Figure 22. Global Herpes Labialis Drugs Sales Market Share by Application (2016-2021)
Figure 23. Global Herpes Labialis Drugs Revenue Market Share by Application in 2020
Figure 24. Global Herpes Labialis Drugs Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Herpes Labialis Drugs Revenue Market Share by Company in 2020
Figure 26. Global Herpes Labialis Drugs Sales Market Share by Regions (2016-2021)
Figure 27. Global Herpes Labialis Drugs Revenue Market Share by Region in 2020
Figure 28. Americas Herpes Labialis Drugs Sales 2016-2021 (K Pcs)
Figure 29. Americas Herpes Labialis Drugs Revenue 2016-2021 ($ Millions)
Figure 30. APAC Herpes Labialis Drugs Sales 2016-2021 (K Pcs)
Figure 31. APAC Herpes Labialis Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Europe Herpes Labialis Drugs Sales 2016-2021 (K Pcs)
Figure 33. Europe Herpes Labialis Drugs Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Herpes Labialis Drugs Sales 2016-2021 (K Pcs)
Figure 35. Middle East & Africa Herpes Labialis Drugs Revenue 2016-2021 ($ Millions)
Figure 36. Americas Herpes Labialis Drugs Sales Market Share by Country in 2020
Figure 37. Americas Herpes Labialis Drugs Revenue Market Share by Country in 2020
Figure 38. Americas Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 39. Americas Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 40. United States Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Herpes Labialis Drugs Sales Market Share by Region in 2020
Figure 45. APAC Herpes Labialis Drugs Revenue Market Share by Regions in 2020
Figure 46. APAC Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 47. APAC Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 48. China Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Herpes Labialis Drugs Sales Market Share by Country in 2020
Figure 55. Europe Herpes Labialis Drugs Revenue Market Share by Country in 2020
Figure 56. Europe Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 57. Europe Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 58. Germany Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Herpes Labialis Drugs Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Herpes Labialis Drugs Sales Market Share by Application in 2020
Figure 67. Egypt Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Herpes Labialis Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles


★調査レポート[世界の口唇ヘルペス薬市場予測 2021年-2026年] (コード：LPI21MY9635)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の口唇ヘルペス薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の皮膚科用医薬品市場予測 2021年-2026年
    LPI21MY9505 / LP Information / 2021年5月 / LPインフォメーション社の「皮膚科用医薬品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、処方薬、市販薬など、用途別には、にきび、皮膚感染症、乾癬、皮膚炎治療薬、その他などにセグメント区分してまとめました。皮膚科用医薬品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・皮膚科用医薬品の世界市場概要（サマリー） ・皮膚科用医薬品の企業別販売量・売上 ・皮膚科用医薬品の企業別市場シェア ・皮膚科用医薬品の世界市場規模 2016年-2021年：種類別（処方薬、市販薬） ・皮膚科用医薬品の世界市場規模 2016年-2021年：用途別（にきび、皮膚感染症、乾癬、皮膚炎治療薬、その他） ・皮膚科用医薬品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・皮膚科用医薬品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Dermatological Drugs will have significant change from previous year. By the most conservative estimates of global Dermatological Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 23840 million in 2019. Over the next five years the Dermatological Drugs market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 28840 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Dermatological Drugs market by product type, application, key manufacturers and...
  • 世界の点眼薬市場予測 2021年-2026年
    LPI21MY9609 / LP Information / 2021年5月 / LPインフォメーション社の「点眼薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬など、用途別には、緑内障、ドライアイ症候群、網膜疾患、その他などにセグメント区分してまとめました。点眼薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・点眼薬の世界市場概要（サマリー） ・点眼薬の企業別販売量・売上 ・点眼薬の企業別市場シェア ・点眼薬の世界市場規模 2016年-2021年：種類別（網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬） ・点眼薬の世界市場規模 2016年-2021年：用途別（緑内障、ドライアイ症候群、網膜疾患、その他） ・点眼薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・点眼薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Ophthalmol Drugs will have significant change from previous year. By the most conservative estimates of global Ophthalmol Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Ophthalmol Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmol Drugs market by product type, application, key manufacturers and...
  • 世界の抗てんかん薬市場予測 2021年-2026年
    LPI21MY9417 / LP Information / 2021年5月 / LPインフォメーション社の「抗てんかん薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、第一世代、第二世代など、用途別には、病院、クリニック、研究などにセグメント区分してまとめました。抗てんかん薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗てんかん薬の世界市場概要（サマリー） ・抗てんかん薬の企業別販売量・売上 ・抗てんかん薬の企業別市場シェア ・抗てんかん薬の世界市場規模 2016年-2021年：種類別（第一世代、第二世代） ・抗てんかん薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、研究） ・抗てんかん薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗てんかん薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antiepileptic Drugs will have significant change from previous year. By the most conservative estimates of global Antiepileptic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 3897.5 million in 2019. Over the next five years the Antiepileptic Drugs market will register a 2.2% CAGR in terms of revenue, the global market size will reach US$ 4257.8 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antiepileptic Drugs market by product type, application, key manufacturers and...
  • 世界の止瀉薬市場予測 2021年-2026年
    LPI21MY9409 / LP Information / 2021年5月 / LPインフォメーション社の「止瀉薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、処方薬、OTC薬など、用途別には、子供、成人などにセグメント区分してまとめました。止瀉薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・止瀉薬の世界市場概要（サマリー） ・止瀉薬の企業別販売量・売上 ・止瀉薬の企業別市場シェア ・止瀉薬の世界市場規模 2016年-2021年：種類別（処方薬、OTC薬） ・止瀉薬の世界市場規模 2016年-2021年：用途別（子供、成人） ・止瀉薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・止瀉薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Diarrheal Drugs will have significant change from previous year. By the most conservative estimates of global Anti Diarrheal Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Diarrheal Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Diarrheal Drugs market by product type,...
  • 世界の抗糖尿病薬市場予測 2021年-2026年
    LPI21MY9415 / LP Information / 2021年5月 / LPインフォメーション社の「抗糖尿病薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口薬、注射薬など、用途別には、1型糖尿病、2型糖尿病、妊娠糖尿病、その他などにセグメント区分してまとめました。抗糖尿病薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗糖尿病薬の世界市場概要（サマリー） ・抗糖尿病薬の企業別販売量・売上 ・抗糖尿病薬の企業別市場シェア ・抗糖尿病薬の世界市場規模 2016年-2021年：種類別（経口薬、注射薬） ・抗糖尿病薬の世界市場規模 2016年-2021年：用途別（1型糖尿病、2型糖尿病、妊娠糖尿病、その他） ・抗糖尿病薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗糖尿病薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Antidiabetic Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antidiabetic Drugs market by product type, application, key manufacturers and...
  • 世界の抗片頭痛薬市場予測 2021年-2026年
    LPI21MY9422 / LP Information / 2021年5月 / LPインフォメーション社の「抗片頭痛薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、トリプタン、麦角、その他など、用途別には、女性、男性などにセグメント区分してまとめました。抗片頭痛薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗片頭痛薬の世界市場概要（サマリー） ・抗片頭痛薬の企業別販売量・売上 ・抗片頭痛薬の企業別市場シェア ・抗片頭痛薬の世界市場規模 2016年-2021年：種類別（トリプタン、麦角、その他） ・抗片頭痛薬の世界市場規模 2016年-2021年：用途別（女性、男性） ・抗片頭痛薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗片頭痛薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Migraine Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Migraine Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti-Migraine Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Migraine Drugs market by product type, application, key manufacturers and...
  • 世界の免疫抑制薬市場予測 2021年-2026年
    LPI21MY9646 / LP Information / 2021年5月 / LPインフォメーション社の「免疫抑制薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体など、用途別には、腎臓、骨髄、その他などにセグメント区分してまとめました。免疫抑制薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・免疫抑制薬の世界市場概要（サマリー） ・免疫抑制薬の企業別販売量・売上 ・免疫抑制薬の企業別市場シェア ・免疫抑制薬の世界市場規模 2016年-2021年：種類別（カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体） ・免疫抑制薬の世界市場規模 2016年-2021年：用途別（腎臓、骨髄、その他） ・免疫抑制薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・免疫抑制薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Immunosuppressant Drugs will have significant change from previous year. By the most conservative estimates of global Immunosuppressant Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Immunosuppressant Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Immunosuppressant Drugs market by product type, application, key manufacturers and...
  • 世界のジョサマイシン薬市場予測 2021年-2026年
    LPI21MY9651 / LP Information / 2021年5月 / LPインフォメーション社の「ジョサマイシン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒など、用途別には、病院薬局、小売ドラッグストアなどにセグメント区分してまとめました。ジョサマイシン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ジョサマイシン薬の世界市場概要（サマリー） ・ジョサマイシン薬の企業別販売量・売上 ・ジョサマイシン薬の企業別市場シェア ・ジョサマイシン薬の世界市場規模 2016年-2021年：種類別（ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒） ・ジョサマイシン薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売ドラッグストア） ・ジョサマイシン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ジョサマイシン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Josamycin Drugs will have significant change from previous year. By the most conservative estimates of global Josamycin Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Josamycin Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Josamycin Drugs market by product type, application, key manufacturers and...
  • 世界の神経内分泌がん治療薬市場予測 2021年-2026年
    LPI21MY9603 / LP Information / 2021年5月 / LPインフォメーション社の「神経内分泌がん治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ソマトスタチン類似体、標的療法、化学療法など、用途別には、病院、クリニック、腫瘍学センター、外来手術センターなどにセグメント区分してまとめました。神経内分泌がん治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・神経内分泌がん治療薬の世界市場概要（サマリー） ・神経内分泌がん治療薬の企業別販売量・売上 ・神経内分泌がん治療薬の企業別市場シェア ・神経内分泌がん治療薬の世界市場規模 2016年-2021年：種類別（ソマトスタチン類似体、標的療法、化学療法） ・神経内分泌がん治療薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、腫瘍学センター、外来手術センター） ・神経内分泌がん治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・神経内分泌がん治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Neuroendocrine Carcinoma Drugs will have significant change from previous year. By the most conservative estimates of global Neuroendocrine Carcinoma Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Neuroendocrine Carcinoma Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Neuroendocrine Carcinoma Drugs market by product type,...
  • 世界の精神障害治療薬市場予測 2021年-2026年
    LPI21MY9588 / LP Information / 2021年5月 / LPインフォメーション社の「精神障害治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質＆アルコール中毒治療薬、小児期＆青年期精神障害薬、認知障害治療薬、睡眠障害、その他など、用途別には、子供、青年、大人などにセグメント区分してまとめました。精神障害治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・精神障害治療薬の世界市場概要（サマリー） ・精神障害治療薬の企業別販売量・売上 ・精神障害治療薬の企業別市場シェア ・精神障害治療薬の世界市場規模 2016年-2021年：種類別（統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質＆アルコール中毒治療薬、小児期＆青年期精神障害薬、認知障害治療薬、睡眠障害、その他） ・精神障害治療薬の世界市場規模 2016年-2021年：用途別（子供、青年、大人） ・精神障害治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・精神障害治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Mental Disorders Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Mental Disorders Drugs market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆